FEATURED ARTICLES

• CRO Summit Tackles Cost, Complexity & Collaboration In Trials

  Clinical trials are facing rising costs and complexity. Collaboration, data-driven strategies, and patient-centric models are reshaping research — uncover how leaders drive efficiency and innovation.

• Charlotte: A Global Hub For Health Care Innovation And MedTech

  Charlotte’s Pearl is a vibrant hub driving health care innovation — advancing surgery, diagnostics, and digital health through research, education, and medtech collaboration for global impact.

• New Legislation Seeks To Strengthen U.S. Biomanufacturing Sector

  A bipartisan bill aims to create a national center for biopharma manufacturing — boosting U.S. supply chains, workforce training, and global competitiveness in life-saving innovation.

• Novartis To Invest $771M In RTP, Creating Up To 700 Biologics Jobs

  A $771 million expansion will bring new biologics and small molecule manufacturing capabilities and create hundreds of jobs. Learn how this investment positions the Research Triangle for future growth.

• AI Bringing Both Opportunity And Risk In Drug Development

  AI is transforming drug discovery and clinical trials, but success depends on balancing technology with human expertise and ethics. Learn how industry leaders are navigating this shift to accelerate innovation.

• CRO Crown Bioscience Adds Kannapolis Site

  A new Kannapolis site boosts Crown Bioscience’s preclinical oncology services, expanding its U.S. presence. Learn how this move supports innovation in cancer drug development.

• FUJIFILM Biotechnologies Cuts The Ribbon On New Holly Springs Facility

  A new Holly Springs facility boosts U.S. biologics manufacturing with end-to-end capabilities and supply chain resilience—marking a major investment in North Carolina’s life sciences infrastructure.

• Biogen Celebrates 30 Years In RTP And Donates $250,000 To New Lab

  A new biotech lab at Durham Tech, funded by Biogen’s $250K donation, will expand hands-on training and strengthen workforce development in North Carolina’s growing life sciences sector.

• Ypsomed To Invest $249M, Create 62 New Jobs In Holly Springs

  A $249M investment by Ypsomed will bring 62 new jobs and a cutting-edge auto-injector facility to Holly Springs, reinforcing the region’s role in biomanufacturing and drug delivery innovation.

• Genentech Breaks Ground On $700M Facility In Holly Springs

  A major biotech expansion in North Carolina will focus on next-gen obesity treatments, signaling rising demand and shifting manufacturing priorities. Learn what this means for the future.

• Test Bed In Winston-Salem Boosts Emerging Field Of Regenerative Medicine

  Discover a quiet lab in downtown Winston-Salem that is quietly fueling biotech innovation while offering startups free access to cutting-edge equipment and support.

• Coriolis Pharma Launches At Spark Life Sciences In Morrisville

  Coriolis Pharma is investing $10.8M in Morrisville, NC, to create 50 jobs and launch U.S. operations at Spark Life Sciences with advanced lab space for biologics development and manufacturing.

• Triad Emerging As National Hot Spot For Regenerative Medicine

  Breakthroughs in regenerative medicine are transforming healthcare in Winston-Salem, where experts are developing therapies to help the body heal itself—repairing tissue and even regenerating organs.

• GeneVentiv Targeting Gene Therapies For Hemophilia, Pompe Disease

  Biopharma entrepreneur Damon Race found breakthrough gene and gene-editing therapies close to home, licensing innovations from UNC-Chapel Hill and Duke University, to launch his latest venture.

• Corporate Recombinations Include $50M, New Life For Durham's Pelthos

  Explore how Pelthos Therapeutics partners with Channel Therapeutics to launch its FDA-approved drug, backed by $50 million in new funding to strengthen its position in the global pharmaceutical market.

• FUJIFILM Signs $3B Deal With Regeneron For Biologics Work

  FUJIFILM Biosciences has signed a $3 billion, 10-year deal with Regeneron to manufacture biologics in North Carolina, reinforcing U.S. supply chains and expanding domestic biopharma capabilities.

• Genentech To Build $700M Fill-Finish Facility In Holly Springs

  Genentech will invest $700 million in a new 700,000-square-foot facility in Holly Springs, NC, to create 420 jobs and boost the region’s life sciences and biomanufacturing sector.

• PTRME Founders' Journey Focuses On Entrepreneurs In 'Fireside Chat'

  Examine how PTRME launched its first major workshop, The Founders’ Journey, to empower biotech innovators with tools, mentorship, and connections to accelerate regenerative medicine breakthroughs from research to real-world impact.

• Collaborative Approach Is Key To Successful CGT Clinical Trials

  Cell and gene therapies (CGT) offer hope for innovative treatments, but complex trials strain healthcare resources. Explore how the impact of resource strain delays these transformative therapies for patients in need.

• Azzur Serves NC Biosciences With "Cleanrooms On Demand"

  Find out how a national life sciences service company is helping North Carolina startups by providing state-of-the-art facilities in Morrisville for product development and manufacturing to accelerate growth and streamline operations.